Peptide Synthesis Market Size, Share, Growth Analysis, By Product (Equipment, Peptide Synthesizers), By Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis), By Application (Personalized Therapeutics, Cancer, Metabolic), By End-use, By Region - Industry Forecast 2024-2031.

Global Peptide Synthesis Market size was valued at USD 619.56 million in 2022 and is poised to grow from USD 700.11 million in 2023 to USD 1861.20 million by 2031, growing at a CAGR of 13.0% during the forecast period (2024-2031).

Peptides serve as signaling molecules that interact with specific receptors located on the cell membrane, initiating intracellular responses that regulate various physiological functions and metabolic processes. In recent years, peptides have gained prominence as potential therapeutic agents due to their improved metabolic stability, specificity for biological targets, and greater binding affinity. It is crucial to recognize that peptide-based therapies differ significantly from small molecule drugs and biologics in aspects such as pharmacological research, analytical and process development, impurity analysis, and structural recognition. The peptide synthesis market has experienced substantial growth in recent years, driven by the rising interest in peptide therapeutics.

Demand for peptide synthesis has increased significantly in the past decade and the approval of peptide-based diagnosis therapy solution has witnessed a spike post pandemic. Presently, more than 80 peptide therapeutics have received approval in various regions worldwide for the treatment of numerous chronic conditions, including cancer, chronic pain, diabetes, HIV, multiple sclerosis, and osteoporosis. Furthermore, since 2015, over 630 clinical trials have been actively undertaken to assess the therapeutic efficacy of peptide-based treatments.